We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$1.25T
AUM Growth
-$1.02T
Cap. Flow
-$1.16T
Cap. Flow %
-93.16%
Top 10 Hldgs %
19.22%
Holding
8,154
New
333
Increased
458
Reduced
6,748
Closed
331

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$50.9B
2
AAPL icon
Apple
AAPL
+$38.9B
3
AMZN icon
Amazon
AMZN
+$26B
4
NVDA icon
NVIDIA
NVDA
+$23.3B
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$17B

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 10.81%
3 Healthcare 9.76%
4 Consumer Discretionary 9.08%
5 Industrials 6.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPYI icon
7076
NEOS S&P 500 High Income ETF
SPYI
$10.8B
$286 ﹤0.01%
5
+3
+150% +$148
JFIN
7077
Jiayin Group
JFIN
$113M
$285 ﹤0.01%
43
-131
-75% -$778
LABP
7078
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$279 ﹤0.01%
+13
New +$86
SLDPW icon
7079
Solid Power Inc Warrant
SLDPW
$10.2M
$277 ﹤0.01%
1,370
-1,370
-50% -$261
MAAS
7080
Maase Inc
MAAS
$7.87B
$277 ﹤0.01%
1
NNVC icon
7081
NanoViricides
NNVC
$38.8M
$275 ﹤0.01%
237
-237
-50% -$272
ALPP
7082
DELISTED
Alpine 4 Holdings Inc
ALPP
$275 ﹤0.01%
388
-1,702
-81% -$1.18K
RDHL
7083
Redhill Biopharma
RDHL
$3.95M
$274 ﹤0.01%
21
-25
-54% -$446
NVVE
7084
DELISTED
Nuvve Holding Corp
NVVE
0
BNBX
7085
DELISTED
BNB PLUS CORP
BNBX
0
NCTY
7086
The9 Ltd
NCTY
$68.1M
$258 ﹤0.01%
38
-2,234
-98% -$13K
RAAX icon
7087
VanEck Inflation Allocation ETF
RAAX
$1.12B
$257 ﹤0.01%
9
-7
-44% -$178
SECO
7088
DELISTED
Secoo Holding Limited ADR
SECO
$257 ﹤0.01%
625
-625
-50% -$298
WBX.WS
7089
DELISTED
Wallbox N.V. Warrants, each warrant to purchase one Class A Ordinary Share
WBX.WS
$250 ﹤0.01%
1,250
-1,251
-50% -$152
WHLM
7090
DELISTED
Wilhelmina International, Inc
WHLM
$243 ﹤0.01%
50
-50
-50% -$223
GOVX icon
7091
GeoVax Labs
GOVX
$3.55M
$240 ﹤0.01%
5
-6
-55% -$473
BINI
7092
DELISTED
Bollinger Innovations
BINI
0
AAU
7093
DELISTED
Almaden Minerals Ltd
AAU
$238 ﹤0.01%
1,700
-958,640
-100% -$131K
AMZY icon
7094
YieldMax AMZN Option Income Strategy ETF
AMZY
$268M
$235 ﹤0.01%
10
-10
-50% -$221
LSXMB
7095
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$234 ﹤0.01%
8
-8
-50% -$242
FMED icon
7096
Fidelity Disruptive Medicine ETF
FMED
$44.8M
$230 ﹤0.01%
9
-9
-50% -$222
EVOK
7097
DELISTED
Evoke Pharma
EVOK
$229 ﹤0.01%
31
-32
-51% -$272
SPUU icon
7098
Direxion Daily S&P 500 Bull 2X ETF
SPUU
$253M
$229 ﹤0.01%
1
-1
-50% -$112
CLVR
7099
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$214 ﹤0.01%
44
-44
-50% -$152
OPER icon
7100
ClearShares Ultra-Short Maturity ETF
OPER
$110M
$213 ﹤0.01%
2

Similar funds

Morgan Stanley's Q1 2024 Portfolio in Review

As of Q1 2024, Morgan Stanley held 8,154 positions worth $1.25T, down 45% from $2.27T the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Morgan Stanley withdrew a net $1.16T in Q1 2024, closing 331 positions and reducing 6,748 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $725M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Morgan Stanley opened a new position in Grayscale Bitcoin Trust worth $270M.

  • Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
  • Morgan Stanley added most to Altria Group in Q1 2024, an estimated $428M increase.
  • Morgan Stanley's biggest Q1 2024 reduction was Microsoft, cutting an estimated $50.9B.
  • Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $725M.
  • Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
  • Morgan Stanley opened 333 new positions and closed 331 in Q1 2024.
  • Morgan Stanley's portfolio value fell 45% quarter-over-quarter to $1.25T.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.